Phenomenex (Torrance, California, USA) has announced the creation of a new company Phenova, Inc. ; the culmination of the integration and expansion of Colorado-based Wibby Environmental.
Phenomenex (Torrance, California, USA) has announced the creation of a new company – Phenova, Inc. – the culmination of the integration and expansion of Colorado-based Wibby Environmental. Phenova provides proficiency standards and testing services to environmental laboratories working under strict regulatory guidelines. Together, Phenomenex and Phenova will aim to offer a total solution to environmental customers.
Phenomenex is investing in a 30,000-square-foot modern facility with equipment that will triple the laboratory space in Colorado to accommodate growth. Demonstrating its dedication to providing high-quality products, the company has received additional quality accreditations including ISO/IEC 17025 and ISO Guide 34.
Initially the company will serve customers in the US, but there are plans to expand internationally to meet country-specific environmental regulatory requirements.
Jason Campbell has been named president and general manager of Phenova. Campbell said: “We have nearly doubled the company’s staff since the acquisition process began, and we have made significant investments in our analytical resources.”
Fasha Mahjoor, CEO of Phenomenex, commented: “The acquisition is part of our growth strategy, which centres on providing total solutions to the application areas we serve. This environmental product portfolio is a natural fit with Phenomenex’s offering and we serve the same customers.”
This news follows the release at Pittcon 2012 that Waters (Milford, Massachusetts, USA) would produce a product line of analytical standards and reagents of more than 200 pre-formulated reference materials and reagents for the scientific laboratory. The Water’s manufacturing facility is also based in Colorado.
These moves highlight the importance that these companies regard analytical standards and reagents for the calibration, control, qualification and assessment of analytical or preparative LC, SFC or LC–MS systems.
For more information please visit:
www.phenomenex.comThis story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.